Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Hepatology

Volumn 62, Issue 5, 2015, Pages 1620-1622

  Beuers, Ulrich ^a   Gershwin, M Eric ^b   Gish, Robert G ^c   Invernizzi, Pietro ^d   Jones, David E J ^e   Lindor, Keith ^f   Ma, Xiong ^g   Mackay, Ian R ^h   Parés, Albert ⁱ   Tanaka, Atsushi ^j   Vierling, John M ^k   Poupon, Raoul ^l  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f ARIZONA STATE UNIVERSITY   (United States)

^g SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^h MONASH UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

^j TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l HÔPITAL SAINT ANTOINE   (France)

more..

Author keywords

Cholangiopathy; Cholestasis; Primary biliary cirrhosis

Indexed keywords

ARTICLE; CHOLANGITIS; EARLY DIAGNOSIS; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NOMENCLATURE; PRACTICE GUIDELINE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; BILIARY CIRRHOSIS;

CHOLANGITIS; HUMANS; LIVER CIRRHOSIS, BILIARY; TERMINOLOGY AS TOPIC;

EID: 84945487748     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28140     Document Type: Article

References (21)

1. Addison T, Gull W. On a certain affection of the skin-vitiligoidea a plana, b tuberosa. Guy's Hosp Rep 1851;7:265-276.
2. Hanot V. Study on a form of hypertrophic liver cirrhosis [hypertrophic cirrhosis with chronic jaundice]. Paris: JBBaillère; 1876.
3. MacMahon HE, Thannhauser SJ. Xanthomatous biliary cirrhosis: a clinical syndrome. Ann Intern Med 1949;30:121-179.
4. Ahrens EH, Jr., Payne MA, Kunkel HG, Eisenmenger WJ, Blondheim SH. Primary biliary cirrhosis. Medicine 1950;29:299-364.
5. Sherlock S. Primary biliary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology 1959;37:574-586.
6. Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis chronic non-suppurative destructive cholangitis. Am J Pathol 1965;46:387-407.
7. Sherlock S. Diseases of the Liver and Biliary System. Oxford, UK: Blackwell Scientific; 1968.
8. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237-267.
9. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology 2009;50:291-308.
10. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008;47:737-745.
11. Bianchi I, Carbone M, Lleo A, Invernizzi P. Genetics and epigenetics of primary biliary cirrhosis. Semin Liver Dis 2014;34:255-264.
12. Hirschfield GM, Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Ann Rev Pathol 2013;8:303-330.
13. Lleo A, Maroni L, Glaser S, Alpini G, Marzioni M. Role of cholangiocytes in primary biliary cirrhosis. Semin Liver Dis 2014;34:273-284.
14. Beuers U, Trauner M, Jansen PL, Poupon R. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol 2015;62(1 Suppl):S25-S37.
15. Dyson JK, Hirschfield GM, Adams DH, Beuers U, Mann DA, Lindor KD, Jones DE. Novel therapeutic targets in primary biliary cirrhosis. Nat Rev Gastroenterol Hepatol 2015;12:147-158.
16. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001;108:223-232.
17. Beuers U, Hohenester S, Maillette de Buy Wenniger L, Kremer AE, Jansen PL, Oude Elferink RP. The biliary HCO3 umbrella-a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 2010;52:1489-1496.
18. Hohenester S, Wenniger LM, Paulusma CC, van Vliet SJ, Jefferson DM, Elferink RP, Beuers U. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology 2012;55:173-183.
19. Banales JM, Sáez E, Uriz M, Sarvide S, Urribarri AD, Splinter P, et al. Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 2012;56:687-697.
20. Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010;52:987-998.
21. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. Increased expression of mitochondrial proteins associated with autophagy in biliary epithelial lesions in primary biliary cirrhosis. Liver Int 2013;33:312-320.